Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Redmile Group, LLC
Form 13F · Q2 2026

Redmile Group, LLC

CIK 1425738申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$14.9亿
申報組合市值
39
持倉數量
12
Quarters on record
Top 50
持倉數量

Redmile Group, LLC——持倉

共 39 個持倉中的前 39 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1SRRK Scholar Rock Hldg Corp4.3M−52.5%$2.4亿15.9%
2KRYS Krystal Biotech Inc632,005−6.2%$2.3亿15.8%
3STOK Stoke Therapeutics Inc3.9M−5.2%$1.3亿8.7%
4IMNM Immunome Inc4.9M−11.6%$1.0亿7.0%
5NRIX Nurix Therapeutics Inc4.1M−47.3%$9883万6.6%
6ABSI Absci Corporation6.7M−18.3%$7811万5.2%
7ANNX Annexon Inc11.9M−18.4%$6778万4.6%
8RGNX Regenxbio Inc4.4M+0.0%$5234万3.5%
9STTK Shattuck Labs Inc6.9M+24.4%$4783万3.2%
10NGNE Neurogene Inc1.4M−3.2%$4441万3.0%
11BEAM Beam Therapeutics Inc1.2M−5.9%$3996万2.7%
12AGMB Agomab Therapeutics Nv2.7M+1649.7%$3549万2.4%
13FATE Fate Therapeutics Inc12.9M+0.0%$3476万2.3%
14IDYA Ideaya Biosciences Inc640,202+22.9%$2386万1.6%
15SLN Silence Therapeutics Plc2.2M+0.0%$2377万1.6%
16COGT Cogent Biosciences Inc503,321−26.8%$1948万1.3%
17SLDB Solid Biosciences Inc1.9M−3.1%$1947万1.3%
18NUVB Nuvation Bio Inc3.0M−3.9%$1722万1.2%
19CLDX Celldex Therapeutics Inc New433,921+65.9%$1615万1.1%
20CLYM Climb Bio Inc1.2M—$1599万1.1%
21ALXO Alx Oncology Hldgs Inc7.4M−7.2%$1530万1.0%
22BMRN Biomarin Pharmaceutical Inc265,169+52.5%$1517万1.0%
23XENE Xenon Pharmaceuticals Inc229,374−12.7%$1385万0.9%
24ZYME Zymeworks Inc491,654+0.0%$1285万0.9%
25ADCT Adc Therapeutics Sa11.5M−25.5%$1233万0.8%
26AURA Aura Biosciences Inc1.7M—$1183万0.8%
27ODTX Odyssey Therapeutics Inc425,000—$795万0.5%
28LIVN Livanova Plc93,154−14.0%$766万0.5%
29ESTA Establishment Labs Hldgs Inc88,964−14.0%$763万0.5%
30CBLL Ceribell Inc386,786+0.0%$752万0.5%
31DBVT Dbv Technologies S A410,440−16.5%$673万0.5%
32INSM Insmed Inc51,234—$546万0.4%
33PRME Prime Medicine Inc1.4M−12.6%$513万0.3%
34ATRA Atara Biotherapeutics Inc441,701+0.0%$507万0.3%
35EPRX Eupraxia Pharmaceuticals Inc611,400−12.7%$404万0.3%
36ORIC Oric Pharmaceuticals Inc362,010−12.9%$392万0.3%
37ARDX Ardelyx Inc641,750−12.5%$327万0.2%
38IVVD Invivyd Inc2.6M−1.9%$227万0.2%
39PLRX Pliant Therapeutics Inc772,126+0.0%$88万0.1%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。